Extendicare Inc.

TSX:EXE.TO

Medical - Care Facilities

Healthcare
$28.81 +2.61%

+$0.86 today

Market cap
$2.74B
Beta
1.16
P/E (TTM)
26.4
EPS (TTM)
$1.28
Dividend yield
1.51%
52W Low $12.12High $35.62

Volume 0.86M

Average 0.34M

EXE.TO Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Extendicare Inc.TSX: EXE.TO

Net Income · Q2 FY2026 · quarter ended Jun 2026

Net income dips below year-ago levels

Q2 FY2026 net income of CA$30.85M fell 3.4% year over year, behind the +45.8% change in trailing-twelve-month net income. Sequentially, it fell 24.3% from the prior quarter. Over 3 fiscal years it compounded at +11.6% a year.

Context

  • Net income amounted to 5.8% of revenue in FY2025, up 0.7 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 5 analysts of CA$127.46M (+31.9%) for the fiscal year ending Dec 2026, a step up from the +28.5% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
CA$30.85M-24.3% QoQ
Last fiscal yearDec 2025
CA$96.66M+28.5% YoY
LTMJun 2026
CA$121.28M+45.8% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.4%+42.2%+45.6 pp
1 year+28.5%+31.9%+3.4 pp
3-year CAGR+11.6%+16.4%+4.8 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

CAD · from the cash flow

Latest · FY2025
96.66M CAD
Year-over-year change
+28.5%
4-year CAGR
+70.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How EXE.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +45.8% is the 3rd highest of 7, against a peer median of +36.9%.
  • Net income amounts to 6.1% of revenue for EXE.TO, versus a peer median of 6.0%.
EXE.TO Competitors
Net Income for EXE.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TLRY.TOTilray Brands, Inc.LTM Feb 2026$1.34B USD+41.3%+71.3%155.6%
EXE.TOExtendicare Inc.LTM Jun 2026CA$121.28M CAD+45.8%+11.6%6.1%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$52.22M CAD+32.5%+61.0%4.7%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$38.73M CAD+202.9%-37.9%2.6%
DR.TOMedical Facilities CorporationLTM Mar 2026$33.14M USD-68.8%+19.7%10.9%
CRRX.TOCareRx CorporationLTM Mar 2026CA$27.07M CAD+820.5%—7.2%
CRON.TOCronos Group Inc.LTM Mar 2026$1.52M USD-97.0%-61.5%1.0%
Peer median (excluding EXE.TO) —+36.9%+19.7%6.0%

Competitors are the stored peer set for EXE.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income11.5M69.55M33.98M75.21M96.66M
Depreciation & Amortization38.57M32.12M32.23M33.34M37.25M
Deferred Income Tax6.61M(46K)4.01M23.86M(7.87M)
Stock-Based Compensation3.7M2.64M4.2M1.89M696K
Change in Working Capital9.29M54.06M(41.2M)22.85M57.02M
Accounts Receivables(13.77M)4.04M(29.2M)(3.58M)18.56M
Inventory(11.1M)0000
Accounts Payables11.1M48.62M(14.43M)31.92M25.24M
Other Working Capital23.05M1.4M2.43M(5.48M)13.22M
Other Non-Cash Items(10.59M)(59.46M)(9.94M)(13.51M)(18.54M)
Operating Cash Flow59.08M98.87M23.28M143.64M165.21M
Capital Expenditures(65.18M)(101.63M)(129.41M)(41.95M)(101.81M)
Acquisitions (Net)0253.14M00(75.12M)
Purchases of Investments0000(1.08M)
Sales of Investments00029.47M57.36M
Other Investing Activities5.79M4.13M44.96M3.37M1.63M
Investing Cash Flow(59.39M)155.64M(84.45M)(9.11M)(119.02M)
Debt Repayment(29.98M)(114.23M)18.67M(44.53M)30.61M
Common Stock Issued0000191.52M
Common Stock Repurchased0(35.02M)(11.06M)00
Dividends Paid(42.99M)(42.55M)(40.43M)(40.02M)(41.7M)
Other Financing Activities(1.86M)(56K)1.89M(3.31M)0
Financing Cash Flow(74.84M)(191.86M)(30.93M)(87.87M)180.43M
Effect of Forex Changes(184K)155K000
Net Change in Cash(75.33M)62.65M(92.1M)46.66M226.63M
Free Cash Flow(6.1M)(2.76M)(106.13M)101.69M63.4M

Extendicare Inc.

TSX:EXE.TO

Intrinsic Alpha fair value

Locked

Current Price

$28.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.